Who owns PASITHEA THERAPEUTICS CORP?
- Ticker: KTTA
- CUSIP Number: 70261f202
Tip: Access positions for across all investors
Analyze quarterly positions in Pasithea Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pasithea Therapeutics Corp stock
Who bought or sold PASITHEA THERAPEUTICS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 2.1M | $2.7M | 100% | Dec 2025 |
|
| Ameriprise Financial | 1.9M | $2.5M | 100% | Dec 2025 |
|
| Cable Car Capital | 500k | $645k | 100% | Dec 2025 |
|
| Longwood Capital Partners | 450k | $581k | 100% | Dec 2025 |
|
| Stempoint Capital | 355k | $458k | 100% | Dec 2025 |
|
| AdvisorShares Investments | 305k | $393k | 18% | Dec 2025 |
|
| Persistent Asset Partners | 291k | $375k | 100% | Dec 2025 |
|
| Stonepine Capital Management | 275k | $355k | 100% | Dec 2025 |
|
| Vanguard Group | 98k | $126k | 82% | Dec 2025 |
|
| Citadel Advisors | 67k | $49k | 44% | Sep 2025 |
|
| Jane Street | 59k | $77k | 137% | Dec 2025 |
|
| Geode Capital Management | 55k | $70k | 114% | Dec 2025 |
|
| Two Sigma Investments | 36k | $26k | 100% | Sep 2025 |
|
| Northern Trust | 28k | $36k | 100% | Dec 2025 |
|
| XTX Topco | 21k | $27k | -40% | Dec 2025 |
|
| UBS Group | 13k | $17k | -28% | Dec 2025 |
|
| Hurley Capital | 3.7k | $4.8M | 0% | Dec 2025 |
|
| Tower Research Capital | 2.9k | $3.8k | 142% | Dec 2025 |
|
| SBI Securities | 1.1k | $1.4k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 250.00 | $0 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 150.00 | $108.000000 | 100% | Sep 2025 |
|
Who sold out of Pasithea Therapeutics Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Sep 2025 | 31k | $23k |
| Virtu Financial | Sep 2025 | 25k | $18k |
| Two Sigma Securities | Sep 2025 | 21k | $15k |
| Hrt Financial | Sep 2025 | 11k | $7.0k |